DE69214355T2 - Hepatozytwachstumsfaktor enthaltende Mittel - Google Patents

Hepatozytwachstumsfaktor enthaltende Mittel

Info

Publication number
DE69214355T2
DE69214355T2 DE69214355T DE69214355T DE69214355T2 DE 69214355 T2 DE69214355 T2 DE 69214355T2 DE 69214355 T DE69214355 T DE 69214355T DE 69214355 T DE69214355 T DE 69214355T DE 69214355 T2 DE69214355 T2 DE 69214355T2
Authority
DE
Germany
Prior art keywords
hhgf
heparin
polysaccharide
derivative
hepatocyte growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69214355T
Other languages
German (de)
English (en)
Other versions
DE69214355D1 (de
Inventor
Daiji Naka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Corp filed Critical Mitsubishi Chemical Corp
Application granted granted Critical
Publication of DE69214355D1 publication Critical patent/DE69214355D1/de
Publication of DE69214355T2 publication Critical patent/DE69214355T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Materials For Medical Uses (AREA)
DE69214355T 1991-06-03 1992-06-03 Hepatozytwachstumsfaktor enthaltende Mittel Expired - Fee Related DE69214355T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13127191 1991-06-03
JP3812292 1992-02-25

Publications (2)

Publication Number Publication Date
DE69214355D1 DE69214355D1 (de) 1996-11-14
DE69214355T2 true DE69214355T2 (de) 1997-03-06

Family

ID=26377318

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69214355T Expired - Fee Related DE69214355T2 (de) 1991-06-03 1992-06-03 Hepatozytwachstumsfaktor enthaltende Mittel

Country Status (9)

Country Link
US (2) US5545722A (enExample)
EP (1) EP0517182B1 (enExample)
KR (1) KR100210698B1 (enExample)
AT (1) ATE143810T1 (enExample)
CA (1) CA2070263A1 (enExample)
DE (1) DE69214355T2 (enExample)
ES (1) ES2094848T3 (enExample)
HU (1) HUT62315A (enExample)
TW (1) TW318142B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
TW318142B (enExample) * 1991-06-03 1997-10-21 Mitsubishi Chemicals Co Ltd
GB9306255D0 (en) * 1993-03-25 1993-05-19 Cancer Res Campaign Tech Heparan sulphate oligosaccharides having hepatocyte growth factor binding affinity
US5464815A (en) * 1993-09-08 1995-11-07 Genentech, Inc. Inhibition of heparin-binding
EP0730466A4 (en) * 1993-09-10 1999-04-14 Univ New York COMPOSITIONS AND METHOD FOR INHIBITING THE INVASION OF HEPATOCYTES BY MALARIASPOROZOITES
US6756358B2 (en) 1994-08-19 2004-06-29 Sumitomo Pharmaceuticals Co., Ltd. Therapeutic agent for cartilaginous diseases
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
JP3927248B2 (ja) 1995-07-11 2007-06-06 第一製薬株式会社 Ｈｇｆ凍結乾燥製剤
AU7389496A (en) * 1995-10-05 1997-04-28 Genentech Inc. Methods and compositions for treating vascular stenosis
US6146847A (en) * 1996-11-01 2000-11-14 Genespan Corporation Stabilized transient gene expression
TW529954B (en) * 1998-10-28 2003-05-01 Sankyo Co Agent for treating abnormal bone metabolism
US7829072B2 (en) * 2000-07-14 2010-11-09 Carter Daniel C Serum albumin compositions for use in cleansing or dermatological products for skin or hair
CZ20022231A3 (cs) * 2001-06-29 2003-02-12 Sankyo Company Limited Komplex skládající se z osteoklastogenezi inhibujícího faktoru a polysacharidu
SE525461C3 (sv) 2002-11-28 2005-03-23 Prophymed Ab Ny användning av dextransulfat
TWI328614B (en) * 2002-12-23 2010-08-11 Bristol Myers Squibb Co Product quality enhancement in mammalian cell culture processes for protein production
CA2511520A1 (en) * 2002-12-23 2004-07-15 Bristol-Myers Squibb Company Mammalian cell culture processes for protein production
US20070116768A1 (en) * 2003-12-09 2007-05-24 Michael Chorny Sustained release preparations composed of biocompatible complex microparticles
SE538503C2 (en) 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045534A (ja) * 1983-08-22 1985-03-12 Otsuka Pharmaceut Co Ltd 肝実質細胞増殖因子
EP0412577A1 (de) * 1986-05-09 1991-02-13 Hoechst Aktiengesellschaft Herbizide Mittel
JP2564486B2 (ja) * 1986-07-14 1996-12-18 修治 橋本 肝細胞増殖因子
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
JPH0240399A (ja) * 1988-07-27 1990-02-09 Takeda Chem Ind Ltd 線維芽細胞増殖因子ムテインの複合体あるいは組成物
JPH0247916A (ja) * 1988-08-08 1990-02-16 Nec Corp アナログコンパレータ
US5013714A (en) * 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
US5486599A (en) * 1989-03-29 1996-01-23 The Board Of Trustees Of The Leland Stanford Junior University Construction and use of synthetic constructs encoding syndecan
CA2022752C (en) * 1989-08-11 1998-07-07 Naomi Kitamura Hepatic parenchymal cell growth factor, gene encoding the same, process for producing the factor, and transformants producing the factor
JP2784455B2 (ja) * 1990-05-09 1998-08-06 敏一 中村 肝硬変治療剤
TW318142B (enExample) * 1991-06-03 1997-10-21 Mitsubishi Chemicals Co Ltd

Also Published As

Publication number Publication date
TW318142B (enExample) 1997-10-21
ES2094848T3 (es) 1997-02-01
EP0517182B1 (en) 1996-10-09
KR100210698B1 (ko) 1999-07-15
DE69214355D1 (de) 1996-11-14
US5545722A (en) 1996-08-13
HUT62315A (en) 1993-04-28
ATE143810T1 (de) 1996-10-15
EP0517182A1 (en) 1992-12-09
CA2070263A1 (en) 1992-12-04
KR930000120A (ko) 1993-01-15
US5736506A (en) 1998-04-07
HU9201856D0 (en) 1992-08-28

Similar Documents

Publication Publication Date Title
DE69214355T2 (de) Hepatozytwachstumsfaktor enthaltende Mittel
DE68905516T2 (de) Hemmungsmittel des zellwachstums der glatten muskeln.
DE69518333T2 (de) Polysaccharide mit hohem anteil an iduronsäure
DE3782358T2 (de) Wundheilende zusammensetzung.
DE69033626T2 (de) Mittel zur Hemmung des Komplementsystems hergestellt aus Fucanen aus braunen Algen
DE69231062T2 (de) Morphogen-induzierte Modulation von entzündlichen Antworten
Trelstad et al. Tendon collagen fibrillogenesis: intracellular subassemblies and cell surface changes associated with fibril growth
DE69814352T2 (de) Matrixlose osteogene vorrichtungen und implantate und verfahren zu deren verwendung
DE69724257T2 (de) Verwendung von oxydierter zellulose und ihrer komplexen zur behandlung von chronischen wunden
DE2324717C3 (de) Verfahren zur Herstellung eines stabilen AHF-Konzentrates (Faktor VIII)
DE69020466T2 (de) Collagen-Zubereitungen und Verfahren zur Herstellung davon.
Cohen et al. Onset and localization of collagen synthesis during wound healing in open rat skin wounds
DE3486341T2 (de) Derivate von Dextran mit antikoagulierenden und antikomplementären Eigenschaften, ihre Herstellung und ihre biologischen Anwendungen.
EP1025869B1 (de) Verfahren zur Herstellung von stabilem Alginatmaterial
DE69109886T2 (de) Verfahren zur Herstellung von humanem Faktor VIII und dessen Analogen.
DE69103755T2 (de) Wachstumshormonkristalle und verfahren zu deren herstellung.
DE3686794T2 (de) Reinigung des natuerlichen kolonie-stimulierenden faktors-1.
DE2927841A1 (de) Verfahren zur herstellung einer biologischen zusammensetzung zur verwendung als blutserum-bezugszusammensetzung fuer diagnostische analysezwecke
DE68910113T2 (de) Wachstuminhibierendes mittel und dessen verwendung.
CH641046A5 (de) Verfahren zur herstellung bestaendiger urokinasemittel.
DE69803362T2 (de) O-sulfatierte, bakterielle polysaccharide
DE2403994A1 (de) Herstellung von antisera
DE69832165T2 (de) Hgf zur behandlung von akutem nierenversagen
DE4121891A1 (de) Arzneimittelabgabesystem zur verabreichung von wachstumsfaktoren
DE60112908T2 (de) Verfahren zur herstellung von rekombinanten, nicht hydroxylierten kollagen-polypeptide-fasern und daraus hergestellte fasern

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee